EcoDrugPlus

Substance-P Receptor-Like

Ensembl ID : ENSSMAG00000008797
Gene Symbol: LOC118300682
2 Cross references
193 Possible Orthologues:

Tachykinin Receptor 1a

Ensembl ID : ENSSMAG00000000538
Gene Symbol: TACR1A
2 Cross references
194 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSSMAG00000004276
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSSMAG00000035648
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSSMAG00000026254
Gene Symbol: TACR3L
1 Cross references
218 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSSMAG00000020742
Gene Symbol: TERT
1 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSSMAG00000010721
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSSMAG00000021222
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSSMAG00000009427
Gene Symbol: TYMP
2 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSSMAG00000022942
Gene Symbol: TYMS
2 Cross references
213 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSSMAG00000020135
Gene Symbol: THRB
3 Cross references
388 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSSMAG00000008281
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).